This Funding Opportunity Announcement (FOA) solicits applications to participate in the Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network. The purpose of this FOA is to establish comprehensive, cooperative basic and translational research Centers to carry out in-depth research on prototype members of select virus families that have the potential to emerge as pandemic pathogens. The goal of these Centers will be to develop vaccine and monoclonal antibody strategies for prototype pathogen(s) that can be applied to closely related family members based on shared functional and structural properties. This FOA solicits for Centers proposing research on virus families from Flaviviridae and Togaviridae to be part of the ReVAMPP Network.
The ReVAMPP Network is comprised of ReVAMPP Centers from this FOA (Flaviviridae and Togaviridae) and its companion FOAs soliciting for ReVAMPP Centers focusing on Bunyavirales, Paramyxoviridae and Picornaviridae (see RFA-AI-23-020) and the ReVAMPP Coordinating and Data Sharing Center (CDSC) (see RFA-AI-23-021). ReVAMPP Centers will conduct independent research project(s) and are expected to share information and collaborate under the direction of the ReVAMPP CDSC which is responsible for establishing and maintaining a collaborative ReVAMPP Network platform for data sharing and overall collaboration among the ReVAMPP Centers.
Letter of Intent Due Date(s): 30 days prior to the application due date
Application Due Date: June 8, 2023
RFA-AI-23-019 Expiration Date June 09, 2023